First-in-man Phase I trial of BYK408740, an oral histone deacetylase inhibitor, in patients with advanced malignancies

被引：0

作者：

Ang, J. E. ^{[1
]}

Hauns, B. ^{[2
]}

Mais, A. ^{[2
]}

Parker, A. ^{[1
]}

Lal, R. ^{[1
]}

Olmos, D. ^{[1
]}

Mollenhauer, M. ^{[2
]}

Walz, A. ^{[2
]}

de Bono, J. S. ^{[1
]}

机构：

[1] Royal Marsden Hosp, Drug Dev Unit, Sutton, Surrey, England

[2] Nycomed GmbH, Exploratory Clin Dev, Constance, Germany

来源：

EJC SUPPLEMENTS | 2008年 / 6卷 / 12期

关键词：

D O I：

10.1016/S1359-6349(08)72327-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：123 / 124

页数：2

共 50 条

[31] A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies [J].

Trivedi, Neel D. ;

Armstrong, Samantha ;

Wang, Hongkun ;

Hartley, Marion ;

Deeken, John ;

He, A. Ruth ;

Subramaniam, Deepa ;

Melville, Heather ;

Albanese, Chris ;

Marshall, John L. ;

Hwang, Jimmy ;

Pishvaian, Michael J. .

CANCER MEDICINE, 2021, 10 (06) :1944-1954

[32] A phase 1 trial of the oral DNA methyltransferase inhibitor CC-486 and the histone deacetylase inhibitor romidepsin in advanced solid tumors [J].

Gaillard, Stephanie L. ;

Zahurak, Marianna ;

Sharma, Anup ;

Durham, Jennifer N. ;

Reiss, Kim A. ;

Sartorius-Mergenthaler, Susan ;

Downs, Melinda ;

Anders, Nicole M. ;

Ahuja, Nita ;

Rudek, Michelle A. ;

Azad, Nilofer .

CANCER, 2019, 125 (16) :2837-2845

[33] Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies [J].

O'Connor, OA ;

Heaney, ML ;

Schwartz, L ;

Richardson, S ;

Willim, R ;

MacGregor-Cortelli, B ;

Curly, T ;

Moskowitz, C ;

Portlock, C ;

Horwitz, S ;

Zelenetz, AD ;

Frankel, S ;

Richon, V ;

Marks, P ;

Kelly, WK .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (01) :166-173

[34] A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies [J].

Katharine A. Collier ;

Hugo Valencia ;

Herbert Newton ;

Erinn M. Hade ;

Douglas W. Sborov ;

Robert Cavaliere ;

Ming Poi ;

Mitch A. Phelps ;

Sophia G. Liva ;

Christopher C. Coss ;

Jiang Wang ;

Soun Khountham ;

Paul Monk ;

Charles L. Shapiro ;

Richard Piekarz ;

Craig C. Hofmeister ;

D. Bradley Welling ;

Amir Mortazavi .

Cancer Chemotherapy and Pharmacology, 2021, 87 :599-611

[35] A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies [J].

Collier, Katharine A. ;

Valencia, Hugo ;

Newton, Herbert ;

Hade, Erinn M. ;

Sborov, Douglas W. ;

Cavaliere, Robert ;

Poi, Ming ;

Phelps, Mitch A. ;

Liva, Sophia G. ;

Coss, Christopher C. ;

Wang, Jiang ;

Khountham, Soun ;

Monk, Paul ;

Shapiro, Charles L. ;

Piekarz, Richard ;

Hofmeister, Craig C. ;

Welling, D. Bradley ;

Mortazavi, Amir .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (05) :599-611

[36] Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignancies [J].

Kummar, Shivaani ;

Gutierrez, Martin ;

Gardner, Erin R. ;

Donovan, Erin ;

Hwang, Kyunghwa ;

Chung, Eun Joo ;

Lee, Min-Jung ;

Maynard, Kim ;

Kalnitskiy, Mikhail ;

Chen, Alice ;

Melillo, Giovanni ;

Ryan, Qin C. ;

Conley, Barbara ;

Figg, William D. ;

Trepel, Jane B. ;

Zwiebel, James ;

Doroshow, James H. ;

Murgo, Anthony J. .

CLINICAL CANCER RESEARCH, 2007, 13 (18) :5411-5417

[37] Phase I trial of oral etoposide in combination with celecoxib in patients with advanced malignancies. [J].

Luu, TH ;

Twardowski, P ;

Leong, L ;

Lim, D ;

Morgan, R ;

McNamara, M ;

Portnow, J ;

Ruel, C ;

Shibata, S ;

Synold, T ;

Doroshow, J .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :241S-241S

[38] Phase I first-in-man trial of a novel bromodomain and extra-terminal domain (BET) inhibitor (BI 894999) in patients (Pts) with advanced solid tumors. [J].

Aftimos, Philippe Georges ;

Bechter, Oliver ;

Awada, Ahmad ;

Jungels, Christiane ;

Dumez, Herlinde ;

Huyvaert, Nathalie ;

Costermans, Jo ;

Lee, Chooi ;

Meeus, Marie-Anne ;

Burkard, Ute ;

Musa, Hanny ;

Zhao, Yihua ;

Schoffski, Patrick .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35

[39] Phase I trial of oral cyclophosphamide in combination with celecoxib in patients with advanced malignancies. [J].

Twardowski, P ;

Chow, W ;

Koczywas, M ;

Leong, L ;

Lim, D ;

Margolin, K ;

Morgan, R ;

Ruel, C ;

Shibata, S ;

Synold, T ;

Doroshow, J .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :240S-240S

[40] Cardiac monitoring in phase I trials of a novel histone deacetylase (HDAC) inhibitor LAQ824 in patients with advanced solid tumors and hematologic malignancies [J].

Rowinsky, EK ;

de Bono, J ;

Deangelo, DJ ;

van Oosterom, A ;

Morganroth, J ;

Laird, GH ;

Dugan, M ;

Scott, JW ;

Ottmann, OG .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :224S-224S

← 1 2 3 4 5 →